While the upregulation of DKK3 and ALDOC enhanced differentiation, the downregulation of ID1 may reduce the oncogenic potential, reinforcing the tumor-suppressive effects of the treatment, as demonstrated before [40]. The gene discussed is ID1; the disease is neoplasm.